Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Agios Pharmaceuticals Inc. (NASDAQ:AGIO) jumped $13.28 (74%) to $31.28 in its first day of trading on Wednesday
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury